A118000 Stock Overview
Distributes pharmaceuticals and medical devices in South Korea. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
METACARE CO., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩282.00 |
| 52 Week High | ₩684.00 |
| 52 Week Low | ₩266.00 |
| Beta | 1.15 |
| 1 Month Change | -10.48% |
| 3 Month Change | -22.31% |
| 1 Year Change | -29.50% |
| 3 Year Change | -81.26% |
| 5 Year Change | -91.77% |
| Change since IPO | -97.00% |
Recent News & Updates
Recent updates
A Piece Of The Puzzle Missing From METACARE CO., Ltd.'s (KRX:118000) Share Price
Nov 14
SMEDI Co., Ltd. (KRX:118000) Stock's 25% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Jul 05Subdued Growth No Barrier To SMEDI Co., Ltd. (KRX:118000) With Shares Advancing 27%
Mar 07There Are Some Holes In Wooridul Huebrain's (KRX:118000) Solid Earnings Release
Mar 22What Type Of Returns Would Wooridul Huebrain's(KRX:118000) Shareholders Have Earned If They Purchased Their SharesYear Ago?
Jan 31
Is Wooridul Huebrain (KRX:118000) Using Debt Sensibly?
Dec 25Shareholder Returns
| A118000 | KR Healthcare | KR Market | |
|---|---|---|---|
| 7D | -4.7% | -5.4% | -0.04% |
| 1Y | -29.5% | -26.0% | -12.2% |
Return vs Industry: A118000 underperformed the KR Healthcare industry which returned -26% over the past year.
Return vs Market: A118000 underperformed the KR Market which returned -12.2% over the past year.
Price Volatility
| A118000 volatility | |
|---|---|
| A118000 Average Weekly Movement | 4.1% |
| Healthcare Industry Average Movement | 10.3% |
| Market Average Movement | 6.6% |
| 10% most volatile stocks in KR Market | 12.7% |
| 10% least volatile stocks in KR Market | 3.4% |
Stable Share Price: A118000 has not had significant price volatility in the past 3 months compared to the KR market.
Volatility Over Time: A118000's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2009 | 22 | Soo-Kyung Kim | www.meta-care.co.kr |
METACARE CO., Ltd. distributes pharmaceuticals and medical devices in South Korea. The company sells orthopedic medical devices and consumables; and provides pharmaceutical integration and professional logistics services. It is involved in investment advisory.
METACARE CO., Ltd. Fundamentals Summary
| A118000 fundamental statistics | |
|---|---|
| Market cap | ₩46.47b |
| Earnings (TTM) | -₩5.33b |
| Revenue (TTM) | ₩57.57b |
0.8x
P/S Ratio-8.7x
P/E RatioIs A118000 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A118000 income statement (TTM) | |
|---|---|
| Revenue | ₩57.57b |
| Cost of Revenue | ₩49.90b |
| Gross Profit | ₩7.68b |
| Other Expenses | ₩13.00b |
| Earnings | -₩5.33b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -32.34 |
| Gross Margin | 13.33% |
| Net Profit Margin | -9.25% |
| Debt/Equity Ratio | 6.0% |
How did A118000 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/28 10:19 |
| End of Day Share Price | 2024/12/27 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
METACARE CO., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|